| 1 | Irene Dapía; Aleksandra Tabakov; Laura Espinosa Román; Lucía Díaz; Pedro Arias Lajara; Marta Melgosa; Angel Melgar; Carlota Fernández; Alicia Herranz Estellés; Pablo Lapunzina; Alberto M. Borobia; Antonio J. Carcas. Effect of the CYP3A5, CYP3A4, CYP3A7, ABCB1, POR and NR1I2 genes in the pharmacokinetics of tacrolimus in a pediatric cohort with stable serum concentrations after renal transplantation: study protocol.IBJ Clinical Pharmacology. 1 - 1, pp. e0005. 26/01/2017.,Autor de correspondencia: Si |
|---|---|
| 2 | Alberto M. Borobia; Antonio J. Carcas Sansuán. Ciencia Iberoamericana para el mundo (IBJ Clinical Pharmacology). IBJ Clinical Pharmacology. 1 - 1, pp. e0001. 02/06/2016.,Autor de correspondencia: Si |
| 3 | Miriam Estebanez Muñoz; Francisco García Río; Francisco Javier Arpa Gutierrez; Patricia Martínez; Jorge F. Gómez Cerezo; Alberto M. Borobia; Blas Rojo Moreno-Arrones; Franciso J. Barbado Hernández. Discriminative value of cardiopulmonary progressive exercise test in mitochondrial myopathy and chronic fatigue syndrome. IBJ Plus. 1 - 1, pp. e0002. 02/06/2016.,Autor de correspondencia: No |
| 4 | Alberto M. Borobia; Antonio J. Carcas Sansuan. Implementación de la farmacogenética en la práctica clínica: hacia las estrategias de genotipado anticipado. IBJ Clinical Pharmacology. 1 - 1, pp. e0002. 02/06/2016. Autor de correspondencia: Si |
| 5 | Olga González; Alberto M. Borobia; Elena Durán; Ana Martínez Virto; Manuel Quintana. Prognostic value of soluble urokinase plasminogen activator receptor (SuPAR) in patients with sepsis attended at an emergency department. Urgentia, R. Int. Med. Emergencias. 1 - 4, pp. 14 - 19. 01/2016.,Autor de correspondencia: Si |
| 6 | Juan Mariano Aguilar Mulet; Virginia Alvarez Rodríguez; Alberto M. Borobia Pérez; Rafael Velayos Rubio; María Dolores Ochoa Mazarro; Carmen del Arco Galán. Ensayo clínico randomizado doble ciego y multicentrico para la evaluación del uso de una mezcla de oxido nitroso y oxigeno (N2O2/O2) 50/50 en el tratamiento del colico renal en el servicio de urgencias.Emergencias. 28, pp. 305 - 312. 2016.,Tipo de soporte: Revista,Autor de correspondencia: No |
| 7 | K Nanwani; Andrés Suarez; Alberto M. Borobia; Miriam Estébanez; Manuel Quintana. Albúmina en el paciente crítico: sepsis grave y shock séptico. ¿qué futuro le espera? Una revisión sistemática y crítica de la literatura.Urgentia, R. Int. Med. Emergencias. 1 - 3, pp. 23 - 32. 2015. |
| 8 | Borobia AM; García Erce JA; Martínez Virto AM; Quintana Díaz M. Algunas reflexiones sobre el uso seguro y eficiente de los concentrados de complejo protrombínico. Emergencias. 2015.,Tipo de soporte: Revista,Autor de correspondencia: Si |
| 9 | Miriam Estebanez; Elena Calvin; M. Angélica Rivera; Alberto M Borobia; Ana Martínez Virto; M Pilar Romero;,Rosa Capilla; Manuel Quintana. Early predictors of hospitalisation for patients infected with the influenza a (H1N1) virus assessed in the emergency department.Urgentia, R. Int. Med. Emergencias. 1 - 3, pp. 6 - 10. 2015. (F.Impacto (JCR 2016): 2.917 (Q1)),Autor de correspondencia: No |
| 10 | Alberto M Borobia; Nicolás Medrano; Miriam Estebanez; Rosa Capilla; Elena Calvin; Begoña Reche; Manuel Quintana. Evaluación de la eficacia de las heparinas de bajo peso molecular mediante la monitorización de la actividad del factor anti- Xa cuando son utilizadas a dosis tromboprofilácticas en un servicio de urgencias.Urgentia,,R. Int. Med. Emergencias. 1 - 3, pp. 18 - 22. 2015. (F.Impacto (JCR 2016): 2.917 (Q1)),Autor de correspondencia: Si |
| 11 | Martín Quirós A; Borobia Pérez A; Pertejo Fernández A; Pérez Perilla P; Rivera Núñez A; Martínez Virto AM; Quintana Díaz M. Mortalidad en el traumatismo potencialmente grave atendido en un servicio de urgencias de tercer nivel. Evaluación de la escala pronóstico de mortalidad GAP. Emergencias. 27 - 6, pp. 371 - 374. 2015. (F.Impacto (JCR 2016): 2.917 (Q1)),Tipo de soporte: Revista |
| 12 | Raul Muñoz Romo; Borobia AM; Quintana M; Martínez-Virto AM; Frías J; Carcas AJ. Desarrollo y validación de un programa de toxicovigilancia con detección automatizada de casos en un hopital terciario (SAT-HULP). Emergencias. 25 - 6, pp. 423 - 429. 2013. (F.Impacto (JCR 2016): 2.917 (Q1)),Tipo de soporte: Revista,Posición de firma: 2,Nº total de autores: 6 |
| 13 | Manuel Quintana Díaz; Alberto M Borobia; Claudia Zegarra; M Angelica Ribera Nuñez; Ana M Martínez Virto.,Experiencia del uso de los concentrados de complejo protrombinico en un servicio de Urgencias. Emergencias. 26, pp. 303 - 306. 2013. (F.Impacto (JCR 2016): 2.917 (Q1)),Tipo de soporte: Revista,Autor de correspondencia: No |
| 14 | Manuel Quintana; Borobia AM; Pérez Cachafeiro S; Rodríguez-Borregán JC; García Erce JA. Estudio de coste-efectividad del empleode concentrado de complejo protrombínico en urgencias para evitar las complicaciones de la sobredosificación de anticoagulantes. Emergencias. 24 - 2, pp. 113 - 120. 2012. (F.Impacto (JCR 2016): 2.917 (Q1)),Tipo de soporte: Revista,Posición de firma: 2,Nº total de autores: 5 |
| 15 | García Erce JA; Borobia AM; Fabra S; Quintana Díaz M. Transfusión sanguínea en los servicios de urgencias.,Emergencias. 24 - 5, pp. 417 - 417. 2012. (F.Impacto (JCR 2016): 2.917 (Q1)),Tipo de soporte: Revista,Posición de firma: 2 |
In compliance with the provisions of Law: Law 15/1999 of December 13, Protection of Personal Data (LOPD) and Royal Decree 1720/2007 of 21 December, which approves the Regulations implementing Law 15/1999 (data Protection Law), we inform you that the data provided, as well as those derived from its navigation data may be stored in files IberoAmerican Journals and treated for the purpose of meeting your application and maintaining the relationship established in the forms signed.
If you wish to exercise their rights of access, rectification, cancellation and opposition regarding the data included in their files, you can do so via e-mail: info@ibjournals.com
In compliance with the provisions of Article 10 of Law 34/2002 of July 11, Services Information Society and Electronic Commerce (LSSI-CE), it is reported that this website is owned by IberoAmerican Journals
Those responsible for this Web are:
What are cookies?
A cookie is a small text file that is stored in your browser when you visit almost any web page. Its usefulness is that the web is able to remember your visit when I return to surf this page.
Cookies often store technical information, personal preferences, content personalization, usage statistics, links to social networks, access to user accounts, etc. The purpose of the cookie is to
adapt the content of the web to your profile and needs without cookies services offered by any page be diminished significantly. To see more information on what are cookies, which store, how to delete them,
disable them, etc.,
for more information, please click on the folowing link.
Cookies used in this web site:
Following the guidelines of the Spanish Data Protection Agency we detail the use of cookies does this website in order to inform you with the maximum possible accuracy.
This web site uses the following own cookies:
This web site uses the following Third-party cookies:
Disabling or removing cookies:
At any time you may exercise your right to disable or delete cookies from this website.These actions are performed differently depending on the browser you are using.
Here we leave a quick guide for the most popular browsers.
Additional notes:
What IS a cookie?
A cookie is a harmless text file that is stored in your browser when you visit almost any web page. The usefulness of cookie is that the web is able to remember your visit when I return to surf this page. Although many people do not know the cookies have been in use for 20 years, when the first browsers for the World Wide Web.
What is NOT a cookie?
It is not a virus or a Trojan, not a worm, or spam, or spyware, or open pop-up windows.
What sort of info a cookie stores?
Cookies do not usually store sensitive information about you, such as credit card or bank account information, photographs, your ID or personal information, etc. The data stored are technical, personal preferences, content personalization, etc.
The web server does not associate you as a person if your web browser. In fact, if you regularly browse with Internet Explorer and try to browse the same web with Firefox or Chrome will see that the web does not realize that you are the same person because you are actually associating the browser, not the person.
What type of cookies exists?
What are own and third-party cookies?
Party cookies are those generated by the page you are visiting and third are generated by internal or external providers such as Facebook, Twitter, Google, etc.
What happens if I disable cookies?
Can the cookies be deleted?
Yes. Not only eliminate, also block, general or particular to a specific domain. To remove cookies from a website should go to your browser settings and there you can find the associated domain in question and proceed to its elimination.
Cookie settings for popular browsers
Here's how to access a particular browser cookie Chrome.
Note: These steps may vary depending on the browser version:
Here's how to access a particular browser cookie Internet Explorer follow these steps:
Note: These steps may vary depending on the browser version:
Here's how to access a particular browser cookie Firefox follow these steps:
Note: These steps may vary depending on the browser version:
Here's how to access a particular browser cookie Safari for OSX follow these steps:
Note: These steps may vary depending on the browser version:
Here's how to access a particular browser cookie Safari for iOS follow these steps:
Note: These steps may vary depending on the browser version:
Here's how to access a particular browser cookie Android follow these steps:
Note: These steps may vary depending on the browser version:
Here's how to access a particular browser cookie Windows Phone follow these steps:
Note: These steps may vary depending on the browser version:
Specialist in Clinical Pharmacology. Associate Professor in the Department of Pharmacology at Universidad Autónoma of Madrid. Doctor of the Clinical Pharmacology Service at La Paz University Hospital. Scientific Coordinator of the Clinical Research Unit and Clinical Trials at La Paz University Hospital - IdiPAZ and Deputy chief of the Clinical Trials Unit of the Faculty of Medicine at Universidad Autónoma of Madrid
editor.ajc@ibjournals.com
C/ Arzobispo Morcillo 4, 28029, Madrid, Spain.
Specialist in Clinical Pharmacology. Clinical Professor Collaborator in the Department of Pharmacology at Universidad Autónoma of Madrid. Doctor of the Clinical Pharmacology Service at La Paz University Hospital. Coordinator of the Clinical Research Unit and Clinical Trials at La Paz University Hospital - IdiPAZ
Specialist in Clinical Pharmacology. Professor in the Department of Pharmacology at Universidad Autónoma of Madrid. Head of the Clinical Pharmacology Service at La Paz University Hospital. Director of the Clinical Research Unit and Clinical Trials at La Paz University Hospital - IdiPAZ and Clinical Trials Unit of the Faculty of Medicine at Universidad Autónoma of Madrid
Specialist in Internal Medicine. Infectious Diseases Specialist. Internal Medicine Service Doctor - Central Hospital of Defense "Gómez Ulla", Infectious Diseases Section, Madrid.
Specialist in Clinical Pharmacology. CICAB Clinical Research Center. Health Area of Badajoz. University Hospital Infanta Cristina. Professor Linked to Extremadura Health Service, Department of Medicine, University of Extremadura Holder. Coordinator of the Central Clinical Research Unit and Clinical Trials Health Area of Badajoz, including the Platform for Clinical Research Units and Clinical Trials (SCReN - Spanish Clinical Research Network coordinator of the Latin American Network of pharmacogenetics, Member of the Section. Pharmacogenetics IUPHAR (International Union of Basic and Clinical Pharmacology, Board Member and former Vice President ESPT European Society of Personalized Therapeutics, Vice President Spanish Society of Pharmacogenetics and Pharmacogenomics. Delegate European Medicines Agency EMA Pharmacogenomics Working Party.
Specialist in Internal Medicine - Infectious Diseases. Doctor of Medicine from the Universidad Complutense of Madrid. Corresponding Academician of the Royal Academy of Medicine of the Balearic Islands. Head of the Sub-inspection of Sanitary and Expert Support of the General Inspectorate of Defense Health.
Professor of Pharmacology. Department of Toxicology and Pharmacology. Complutense University of Madrid. He directs a research group whose lines of work focus on the pharmacology of ion channels in the pathophysiology of neuropathic pain and neurodegeneration.
Specialist in Clinical Pharmacology. Professor of Pharmacology, in the Department of Pharmacology, Faculty of Medicine, Universidad Autónoma of Madrid. Researcher of the UAM group "FARMAVASM" (Vascular Pharmacology and Metabolism). Our main lines of research are focused on identifying pharmacological targets that may interfere with and delay the development of vasculopathy in the context of highly prevalent metabolic diseases, such as obesity or type 2 diabetes. Coordinator of the Ph.D. Program in Pharmacology and Physiology of UAM. Deputy Dean of the UAM Medical School between 2011-2015. Member of the board of directors of the Spanish society of pharmacology (since 2014).
Specialist in Immunology. Doctor in Medicine by the Department of Biochemistry of the UAM. Coordinator of the Immunology Service, La Paz University Hospital. Director of the Research Group on lymphocyte pathophysiology in Immunodeficiencies, IdiPAZ. Member of the Steering Committee of the European Reference Network on Pediatric Transplantation, ERN-TRANSPLANTCHILD.
Specialist in Clinical Pharmacology. Head of Pharmacology, Clinic San Carlos and Professor Linked to Clinical Pharmacology and Department of Pharmacology Head. Member of the Governing Board of the Spanish Agency for Medicines and Health Products. Chairman of the Supervisory Board of the Governing Council. second vice president of the National Committee of the Royal Spanish Pharmacopoeia. Research Associate Dean of the Faculty of Nursing, Physiotherapy, and Podiatry, Complutense University of Madrid. General coordinator of the Spanish Platform Support for Clinical Research and Clinical Trials, Carlos III Health Institute.
Cardiovascular and nutritional epidemiology. Department of Preventive Medicine and Public Health. Universidad Autónoma de Madrid and CIBERESP. Professor of Preventive Medicine and Public Health. In recent years he has investigated the role of diet, physical activity and sedentary lifestyle on the onset of frailty syndrome and disability in older adults.
Specialist in Clinical Pharmacology. Head of the Clinical Pharmacology section, University Hospital de La Princesa. Head of the Central Clinical Research Unit and Clinical Trials in the University Hospital de la Princesa, including the Platform for Clinical Research Units and Clinical Trials (SCReN - Spanish Clinical Research Network).
Specialist in Internal Medicine. Professor and Dean of Medicine Department of Medicine, Faculty of Medicine, Autonomous University of Madrid. Deputy Head Section of Internal Medicine and the University Hospital Puerta de Hierro. Co-director of the Department of sponsorship UAM - LAIR Foundation on "Teaching and research in systemic immune-based diseases."
Specialist in Clinical Pharmacology. Master in Pharmacoepidemiology and Master in Medical Ethics. Professor of Pharmacology, Department of Pharmacology, Therapeutics, and Toxicology at the Autonomous University of Barcelona. Head of Clinical Pharmacology, University Hospital Germans Trias i Pujol (HUGTP-GIBT) Badalona, Barcelona). Head of the Clinical Research Unit and Clinical Trials Platform SCReN-ISCIII of the center. His main area of research is the potential for abuse and human pharmacology of drugs and medicines and health consequences.
Specialist in Clinical Pharmacology. Doctor of the University of Cantabria and Master in Clinical Trials by the University of Seville. Head of the Clinical Pharmacology Service of the Hospital Universitario de Canarias. Chairman of the Research Ethics Committee of the Hospital Universitario de Canarias.
Specialist in Clinical Pharmacology. Hepatotoxicity. Clinical trials. Pharmacoepidemiology. Risk factors. Causality. University of Malaga Clinical Pharmacology HUVV. Institute Malaga Biomedical Research. IBIMA. Professor in the Department of Pharmacology and Pediatrics and Director of the department of pharmacology and pediatrics of the faculty of medicine, University of Malaga. Scientific director of the Institute for Biomedical Research in Malaga, IBIMA. Head of Clinical Pharmacology, University Hospital Virgen de la Victoria Malaga and Coordinator of the platform for clinical research and clinical trials, IBIMA node, the Health Institute Carlos III. Member of the executive committee IUPHAR (International Union of Basic and Clinical Pharmacology) and the division of clinical pharmacology IUPHAR.
Specialist in Clinical Pharmacology. Hospital General Universitario of Alicante. Professor of Pharmacology. Department of Pharmacology, Universidad Miguel Hernández of Elche.
Director, Clinical Research, BUC Program (Biociencias UAM + CSIC) of the Universidad Autonoma de Madrid. For more than 20 years, he has been director of the Medical Department in several multinational companies in the pharmaceutical industry. Also, it has been Manager of Clinical Research Program (Alzheimer) of Pasqual Maragall (Barcelona) Foundation between 2010 and 2012. Fellow of the Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians of the United Kingdom (1998-2010). Member of the National Commission of Pharmacovigilance (Mystery of Health) (1993-1996). The author of three books of ethics in clinical and epidemiological research.
Specialist in Pneumology. Head of Service of Pneumology. Hospital Universitario La Paz. Professor of Pulmonology, HULP, and La Universidad Autónoma de Madrid. He was the Medical Director of HULP. Areas of interest: Pneumology: interstitial lung diseases, COPD, sleep apnea-hypopnea syndrome, pneumonia, etc.
Specialist in Clinical Pharmacology. Coordinator of the Research Unit of the Hospital Universitario de Canarias. Associate professor in the Department of Pharmacology and Medical Physics of the University of La Laguna. Master in Clinical Trials. Master in Safety and Quality Assistive Patient. Higher Diploma in research methodology.
Specialist in Cardiology. Master's Degree in Cardiology and Acute Cardiac Care. Department of Cardiology, Central Hospital of Defense "Gómez Ulla". Associate Professor, University of Alcalá. Member of the Directors Board of the Spanish Society of Cardiology.
Specialist in Occupational Medicine. Professor of the "CEPI" Center for Postgraduate Studies and Research of the Universidad Mayor Real and Pontificia de San Francisco Xavier de Chuquisaca (UMRPSFXCH), Bolivia. Labour Doctor at "Prevensalud Integral". Expert in brief psychotherapy and clinical hypnosis.
Microbiology. Director of the Molecular Microbiology Group at the Microbiology Service of La Paz Hospital, IdiPAZ.
Internal Medicine. Medical Assistant. HIV unit. Internal Medicine Service. University Hospital La Paz. IdiPAZ.
Specialist in Clinical Pharmacology. She is part of the management area and monitoring of clinical trials in UICEC-IBIMA for the hospitals Virgen de la Victoria and Malaga Regional. She has participated as a collaborator in the managing of diverse national multi-centric projects from the SCReN platform, as well as in international projects related to drug safety (Project from the IMI SAFE-T Consortium and PRO EURO DILI- Grant Project from the European Association for the study of the liver - EASL). She takes part in the Spanish DILI Register. She is currently developing her doctoral thesis in the Biomedicine program of the University of Malaga, on drug-induced liver toxicity.
Specialist in Clinical Pharmacology and Family and Community Medicine. Adjunct Physician of the Clinical Research Unit of the Jiménez Díaz Foundation, where he carries out scientific and methodological advisory work, support for the development and promotion of independent clinical research. Vocal of the CEIC of Severo Ochoa Hospital of Leganés. Technical Secretary of the CEIC and FJD.
Specialist in Gastroenterology. Head of the Digestive System Section at La Paz University Hospital. Associate Professor of Medicine at the Autonomous University of Madrid. In charge of the creation and development of the Inflammatory Bowel Disease Unit in HULP. In charged of the Hospital´s Endoscopy Unit. She has participated in multiple clinical trials and research studies with multiple national and international publications.
Specialist in Internal Medicine. Master of Infection in the Immunodepressed Patient "at the Complutense University. Trained in the Infectious Diseases Service of the Clinic Hospital of Barcelona and in the Multi-Organ Transplant Program at the Toronto General Hospital. The beneficiary of a contract "Juan Rodés" of the Carlos III Health Institute. His main line of research focuses on infection in the solid organ transplant recipient, in the development and validation of immunological monitoring strategies in this population, and invasive fungal infection. He is the author or co-author of more than 130 publications in national and international journals and received, among others, the "Young Internist of the Year 2014" Award for his research activity.
Specialist in Medical Oncology. Responsible for the heredofamilial cancer unit in the Department of Medical Oncology at La Paz University Hospital. Associate professor of health sciences at the Universidad Autónoma de Madrid.
Specialist in Family and Community Medicine and Clinical Pharmacology. Currently, she works as Clinical Pharmacologist in the Foundation for Biomedical Research of the University Hospital of Getafe in Madrid, Spain. She has over 13 years of experience in clinical trials, 6 of which focused on the elderly population. She is now participating as a co-researcher on three international research projects funded by the European Commission: MID FRIL, SPRINTT and ACANTO. Two of these are clinical trials in elderly subjects in Europe. He is currently responsible for the Clinical Trials Unit in the elderly of the University Hospital of Getafe (CICA) and also works as a clinical pharmacologist on the Ethics Committee of the University Hospital of Getafe.